The purinergic P2Y14 receptor axis is a molecular determinant for organism survival under in utero radiation toxicity

Cell Death and Disease

Volumn 4, Issue 7, 2013, Pages

  Kook, S H ^a,h   Cho, J S ^a   Morrison, A ^b   Wiener, E ^c   Lee, S B ^d   Scadden, D ^e,f,g   Lee, B C ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^f HARVARD STEM CELL INSTITUTE   (United States)

^g Harvard University   (United States)

^h Chonbuk National University   (South Korea)

Author keywords

Embryo; In utero radiation; Purinergic receptors

Indexed keywords

PURINERGIC P2Y RECEPTOR; PURINERGIC P2Y14 RECEPTOR; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE GLUCOSE; P2RY14 PROTEIN, MOUSE; PURINERGIC P2 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; FETUS RISK; GENE DELETION; GENOTOXICITY; MALE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRENATAL EXPOSURE; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIATION INJURY; SURVIVAL; ANIMAL; ATROPHY; BODY WEIGHT; DNA DAMAGE; DRUG EFFECT; ENVIRONMENTAL EXPOSURE; GENETICS; HYDROCEPHALUS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PREGNANCY; RADIATION DOSE; SPLEEN; WHOLE BODY RADIATION; DEFICIENCY; DRUG EFFECTS; PREVENTION AND CONTROL; RADIATION INJURIES, EXPERIMENTAL;

ANIMALS; ATROPHY; BODY WEIGHT; DNA DAMAGE; FEMALE; HYDROCEPHALUS; MALE; MATERNAL EXPOSURE; MICE; MICE, KNOCKOUT; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RADIATION INJURIES, EXPERIMENTAL; RADIATION TOLERANCE; RECEPTORS, PURINERGIC P2; SPLEEN; URIDINE DIPHOSPHATE GLUCOSE; WHOLE-BODY IRRADIATION; RECEPTORS, PURINERGIC P2Y;

EID: 84881032561     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.218     Document Type: Article

References (27)

1. Lazarus E, Debenedectis C, North D, Spencer PK, Mayo-Smith WW. Utilization of imaging in pregnant patients: 10-year review of 5270 examinations in 3285 patients-1997-2006. Radiology 2009; 251: 517-524.
2. Burnstock G. Discovery of purinergic signalling, the initial resistance and current explosion of interest. Br J Pharmacol 2012; 167: 238-255.
3. Glaser T, Resende RR, Ulrich H. Implications of purinergic receptor-mediated intracellular calcium transients in neural differentiation. Cell Commun Signal 2013; 11: 12.
4. Abbracchio MP, Burnstock G. Purinergic signalling: pathophysiological roles. Jpn J Pharmacol 1998; 78: 113-145.
5. Tsukimoto M, Homma T, Ohshima Y, Kojima S. Involvement of purinergic signaling in cellular response to gamma radiation. Radiat Res 2010; 173: 298-309.
6. Rossi L, Salvestrini V, Ferrari D, Di Virgilio F, Lemoli RM. The sixth sense: hematopoietic stem cells detect danger through purinergic signaling. Blood 2012; 120: 2365-2375.
7. Chen JF, Huang Z, Ma J, Zhu J, Moratalla R, Standaert D et al. A(2 A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J Neurosci 1999; 19: 9192-9200.
8. Matos JE, Robaye B, Boeynaems JM, Beauwens R, Leipziger J. K\+ secretion activated by luminal P2Y2 and P2Y4 receptors in mouse colon. J Physiol 2005; 564(Pt 1): 269-279.
9. Wells DG, Zawisa MJ, Hume RI. Changes in responsiveness to extracellular ATP in chick skeletal muscle during development and upon denervation. Dev Biol 1995; 172: 585-590.
10. Lee BC, Cheng T, Adams GB, Attar EC, Miura N, Lee SB et al. P2Y-like receptor, GPR105 (P2Y14), identifies and mediates chemotaxis of bone-marrow hematopoietic stem cells. Genes Dev 2003; 17: 1592-1604.
11. Lazarowski ER, Shea DA, Boucher RC, Harden TK. Release of cellular UDP-glucose as a potential extracellular signaling molecule. Mol Pharmacol 2003; 63: 1190-1197.
12. Dekaban AS. Effects of x-radiation on mouse fetus during gesttion: emphasis on distribution of cerebral lesions, Part II. J Nucl Med 1969; 10: 68-77.
13. Heikenwalder M, Prinz M, Zeller N, Lang KS, Junt T, Rossi S et al. Overexpression of lymphotoxin in T cells induces fulminant thymic involution. Am J Pathol 2008; 172: 1555-1570.
14. Martiney MJ, Rulli K, Beaty R, Levy LS, Lenz J. Selection of reversions and suppressors of a mutation in the CBF binding site of a lymphomagenic retrovirus. J Virol 1999; 73: 7599-7606.
15. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 1993; 362: 847-849.
16. Campisi J, d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007; 8: 729-740.
17. Gilbert-Barness E. Teratogenic causes of malformations. Ann Clin Lab Sci 2010 Spring 40: 99-114.
18. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991; 51(23 Pt 1): 6304-6311.
19. Yu H, Shen H, Yuan Y, XuFeng R, Hu X, Garrison SP et al. Deletion of Puma protects hematopoietic stem cells and confers long-term survival in response to high-dose gammairradiation. Blood 2010; 115: 3472-3480.
20. Qiu W, Carson-Walter EB, Liu H, Epperly M, Greenberger JS, Zambetti GP et al. PUMA regulates intestinal progenitor cell radiosensitivity and gastrointestinal syndrome. Cell Stem Cell 2008; 2: 576-583.
21. Bassil AK, Bourdu S, Townson KA, Wheeldon A, Jarvie EM, Zebda N et al. UDP-glucose modulates gastric function through P2Y14 receptor-dependent and-independent mechanisms. Am J Physiol Gastrointest Liver Physiol 2009; 296: G923-G930.
22. Zhao W, Diz DI, Robbins ME. Oxidative damage pathways in relation to normal tissue injury. Br J Radiol 2007; 1: S23-S31.
23. Jia D, Koonce NA, Griffin RJ, Jackson C, Corry PM. Prevention and mitigation of acute death of mice after abdominal irradiation by the antioxidant N-acetyl-cysteine (NAC). Radiat Res 2010; 173: 579-589.
24. Liu Y, Zhang H, Zhang L, Zhou Q, Wang X, Long J et al. Antioxidant N-acetylcysteine attenuates the acute liver injury caused by X-ray in mice. Eur J Pharmacol 2007; 575: 142-148.
25. Metcalf D, Di Rago L, Mifsud S, Hartley L, Alexander WS. The development of fatal myocarditis and polymyositis in mice heterozygous for IFN-gamma and lacking the SOCS-1 gene. Proc Natl Acad Sci USA 2000; 97: 9174-9179.
26. Cho J, Shen H, Yu H, Li H, Cheng T, Lee SB et al. Ewing sarcoma gene Ews regulates hematopoietic stem cell senescence. Blood 2011; 117: 1156-1166.
27. Johnson GA, Ali-Sharief A, Badea A, Brandenburg J, Cofer G, Fubara B et al. Highthroughput morphologic phenotyping of the mouse brain with magnetic resonance histology. Neuroimage 2007; 37: 82-89.